The invention concerns pyrazine derivatives of the Formula (I) or pharmaceutically-acceptable salts thereof； wherein each of n, m and R has any of the meanings defined hereinbefore in the description； processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of bone-related disorders or conditions.
